Please use this identifier to cite or link to this item:
http://hdl.handle.net/10201/52387
Title: | New models towards assessing anti-cancer therapeutics |
Issue Date: | 2012 |
Publisher: | F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología |
Citation: | Histology and histopathology, Vol. 27, nº 2 (2012) |
ISSN: | 1699-5848 0213-3911 |
Related subjects: | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología |
Keywords: | Cancer Treatment |
Abstract: | Cancer is the subject of intense research around the world, but many questions about how the disease works remain unanswered. How exactly does cancer start and how do tumours grow? In fact, at present there are ten times more anticancer drugs being tested in clinical trials than there were 15 years ago. However, many of the new anticancer agents are predicted to show clinical benefit in only small subpopulations of patients. The cancer stem cell model could explain not only how some cancers work but also why patients suffer relapses, providing a good opportunity to gain insight into the reasons why agents work or, more commonly, don’t work, before going into a clinical trial |
Primary author: | Romero Camarero, Isabel Barajas Diego, Marcos Castellanos Martín, Andrés García Martín, Ángel Varela, Gonzalo Abad, Mar Ludeña, María Dolores Pérez Losada, Jesús Sánchez García, Isidro |
URI: | http://hdl.handle.net/10201/52387 |
Document type: | info:eu-repo/semantics/article |
Number of pages / Extensions: | 14 |
Rights: | info:eu-repo/semantics/openAccess |
Appears in Collections: | Vol.27, nº 2 (2012) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Romero-Camarero-27-157-170-2012.pdf | 896,74 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License